Large-scale Swedish study discovers link between height and cancer

Link between height and cancer

 

Bristol, UK (October 1, 2015) – Cancer risk has been found to increase with height in both Swedish men and women, according to research presented today at the 54th Annual European Society for Paediatric Endocrinology Meeting. This long-term study is the largest carried out on the association between height and cancer in both genders.


Researchers from the Karolinska Institutet and University of Stockholm examined 5.5 million men and women in Sweden, born between 1938 and 1991 and with adult heights ranging between 100 cm and 225 cm. They followed the group of individuals from 1958 or from the age of 20 until the end of 2011, and found that for every 10 cm of height, the risk of developing cancer increased by 18% in women and 11% in men. Additionally, taller women had a 20% greater risk of developing breast cancer, whilst the risk of developing melanoma increased by approximately 30% per 10 cm of height in both men and women.

 

Previous studies have also shown the same association between height and cancer. That is to say, taller individuals have a higher risk of developing different types of cancer, including breast cancer and melanoma. However, this association has never been studied in men and women on such a large scale before. "To our knowledge, this is the largest study performed on linkage between height and cancer including both women and men," said Dr Emelie Benyi, a PhD student at Karolinska Institutet who led the study.

 

The data on adult heights was collected from the Swedish Medical Birth, the Swedish Conscription, and the Swedish Passport Registers, whereas the cancer data was retrieved from the Swedish Cancer Register. "It should be emphasised that our results reflect cancer incidence on a population level," said Dr Benyi. "As the cause of cancer is multifactorial, it is difficult to predict what impact our results have on cancer risk at the individual level."

 

The group is now planning on investigating how mortality from cancer and other causes of death are associated with height within the Swedish population. "Our studies show that taller individuals are more likely to develop cancer but it is unclear so far if they also have a higher risk of dying from cancer or have an increased mortality overall," said Dr Benyi.

 


BioScientifica Limited, 01.10.2015 (tB).

MEDICAL NEWS

Fitness watches generate useful information, but increase patient anxiety
A new device provides added protection against COVID-19 during endoscopic…
81 million Americans lacking space or bathrooms to follow COVID…
Front-line physicians stressed and anxious at work and home
EULAR: High-Dose Glucocorticoids and IL-6 Receptor inhibition can reduce COVID-19…

SCHMERZ PAINCARE

Wie ein Schmerz den anderen unterdrückt
Opioidtherapien im palliativen Praxisalltag: Retardierte Analgetika zeigen Vorteile
Krankenhäuser und Praxen müssen sich bei der Schmerztherapie nach Operationen…
Morbus Fabry mittels Datenanalysen aus dem PraxisRegister Schmerz aufspüren
Neandertaler besaßen niedrigere Schmerzschwelle

DIABETES

Typ-2-Diabetes: Neue Hinweise bestärken die Bedeutung von Übergewicht für Spätfolgen
Suliqua®: Eine sinnvolle Option, wenn die BOT zur Blutzuckerkontrolle nicht…
„Körperstolz“: Michael Krauser managt seinen Diabetes digital
Der richtige Sensor – von Anfang an
Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen

ERNÄHRUNG

Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Fast Food, Bio-Lebensmittel, Energydrinks: neue Daten zum Ernährungsverhalten in Deutschland
Neue Daten zur Ernährungssituation in deutschen Krankenhäusern und Pflegeheimen: Mangelernährung…
Baxter: Parenterale Ernährung von Patienten mit hohem Aminosäurenbedarf

ONKOLOGIE

Bestmögliche Versorgungssicherheit bei der Krebstherapie mit CAR-T-Zellen
Darolutamid bei Prostatakarzinom: Hinweis auf beträchtlichen Zusatznutzen
Multiples Myelom: Wissenschaftler überprüfen den Stellenwert der Blutstammzelltransplantation
Neues zur onkologischen Supportiv- und Misteltherapie und aktuelle Kongress-Highlights zum…
Neue Darreichungsform zur Antiemese bei Chemotherapie: Akynzeo® ist ab sofort…

MULTIPLE SKLEROSE

Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei aktiver…
Neurofilamente als Diagnose- und Prognosemarker für Multiple Sklerose
Bedeutung der Langzeittherapie bei Multipler Sklerose – mehr Sicherheit und…
Bristol Myers Squibb erhält Zulassung der Europäischen Kommission für Ozanimod…
Einige MS-Medikamente könnten vor SARS-CoV-2/COVID-19 schützen

PARKINSON

Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…
Putzfimmel im Gehirn
Parkinson-Patienten in der Coronakrise: Versorgungssituation und ein neuer Ratgeber
Neuer Test: Frühzeitige Differenzialdiagose der Parkinson-Erkrankung
Gegen das Zittern: Parkinson- und essentiellen Tremor mit Ultraschall behandeln…